SEARCHED TERM

Drug-susceptibility testing (DST)

DEFINITION

In vitro testing using phenotypic methods to determine whether M. tuberculosis is susceptible to a particular drug. Also known as antimicrobial susceptibility testing (AST).

MORE INFO

SOURCE DEFINITION

In vitro testing using either phenotypic methods to determine susceptibility or molecular techniques to detect resistance-conferring mutations to a particular medicine

From: WHO
Year: 2016

OTHER DEFINITIONS

TERM 1

Laboratory test that determines whether the M. tuberculosis bacteria cultured from a patient’s isolate are susceptible or resistant to various first-line or secondline anti-TB drugs

From: CDC
Year: 2006

TERM 2

Laboratory determination to assess whether an M. tuberculosis complex isolate is susceptible or resistant to anti-TB drugs that are added to mycobacterial growth medium. The results predict whether a specific drug is likely to be effective in treating TB disease caused by that isolate

From: CDC
Year: 2005

TERM 3

Laboratory determination to assess whether an M. tuberculosis complex isolate is susceptible or resistant to antituberculosis drugs that are added to mycobacterial growth medium or are detected genetically. The results predict whether a specific drug is likely to be effective in treating TB disease caused by that isolate

From: CDC
Year: 2005

TERM 4

Laboratory test that determines whether the M. tuberculosis bacteria cultured from a patient’s isolate are susceptible or resistant to various first-line or secondline anti-TB drugs

From: CDC
Year: 2006

TERM 5

Laboratory determination to assess whether an M. tuberculosis complex isolate is susceptible or resistant to anti-TB drugs that are added to mycobacterial growth medium. The results predict whether a specific drug is likely to be effective in treating TB disease caused by that isolate

From: CDC
Year: 2005

TERM 6

Laboratory determination to assess whether an M. tuberculosis complex isolate is susceptible or resistant to antituberculosis drugs that are added to mycobacterial growth medium or are detected genetically. The results predict whether a specific drug is likely to be effective in treating TB disease caused by that isolate

From: CDC
Year: 2005

TERM 7

In vitro testing using either molecular, genotypic techniques to detect resistance-conferring mutations, or phenotypic methods to determine susceptibility to a medicine.

From: WHO
Year: 2022

TERM 8

in vitro testing using either molecular or genotypic techniques to detect resistance-conferring mutations, or phenotypic methods to determine susceptibility to a medicine.

From: WHO
Year: 2022

TERM 9

in vitro testing using either molecular or genotypic techniques to detect resistance-conferring mutations, or phenotypic methods to determine susceptibility to a medicine.

From: WHO
Year: 2022

TERM 10

In vitro testing using either molecular genotypic techniques to detect resistance-conferring mutations, or phenotypic methods to determine susceptibility to a medicine

From: WHO
Year: 2022

TERM 11

In vitro testing using either: 1) molecular, genotypic techniques to detect resistance-conferring mutations; or 2) phenotypic methods to determine susceptibility to a medicine.1

From: WHO
Year: 2022

CLOSE

TB DICTIONARY

Search for more terms